Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma

MLA

Wenlin Shao, et al. “Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.” Blood, vol. 110, Nov. 2007, p. 1510. EBSCOhost, https://doi.org/10.1182/blood.v110.11.1510.1510.

APA

Wenlin Shao, Yung-Mae Yao, Minying Pu, Peter Atadja, Jane Cheng, Joseph D. Growney, Andrew Spencer, Kenneth C. Anderson, Colleen Kowal, Christine Miller, Stephen Fawell, Brant Firestone, Youzhen Wang, Joseph Eckman, & Jesús F. San Miguel. (2007). Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma. Blood, 110, 1510. https://doi.org/10.1182/blood.v110.11.1510.1510

Chicago

Wenlin Shao, Yung-Mae Yao, Minying Pu, Peter Atadja, Jane Cheng, Joseph D. Growney, Andrew Spencer, et al. 2007. “Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.” Blood 110 (November): 1510. doi:10.1182/blood.v110.11.1510.1510.